Dose escalation schedule: difference between revisions
Diff·revision 11 → 12·04:58, 1 Mar 2025
Difference between revision 11 and revision 12 of Dose escalation schedule. 6 lines changed; the page grew by 122 bytes.
| Revision 11 — 20:08, 13 Feb 2025 PreregPriya (talk) add the note that a smaller diluent volume raises concentration, not dose 3,510 bytes ±0 | Revision 12 — 04:58, 1 Mar 2025 ArchiveBot (talk) bot: normalise citation format 3,632 bytes +122 | ||
|---|---|---|---|
| 37 | <ref name="wilding2021">Wilding JPH, Batterham RL, Calanna S, et al. "Once-weekly semaglutide in adults with overweight or obesity." ''New England Journal of Medicine'' 384(11):989–1002 (2021). PMID 33567185.</ref> | 37 | <ref name="wilding2021">Wilding JPH, Batterham RL, Calanna S, et al. "Once-weekly semaglutide in adults with overweight or obesity." ''New England Journal of Medicine'' 384(11):989–1002 (2021). PMID 33567185.</ref> |
| 38 | 38 | ||
| + | 39 | == See also == | |
| + | 40 | * [[Dose titration]] | |
| + | 41 | * [[Missed dose]] | |
| + | 42 | * [[Adverse effects of GLP-1 receptor agonists]] | |
| + | 43 | * [[Semaglutide]] | |
| + | 44 | ||
| 39 | {{DEFAULTSORT:Dose escalation schedule}} | 45 | {{DEFAULTSORT:Dose escalation schedule}} |
| 40 | [[Category:Dosing and titration]] | 46 | [[Category:Dosing and titration]] |